BeStock  
Stocks › Biotechnology › TBPH

Theravance Biopharma(Delisted) TBPH

US equityMarket cap rank #3323Biotechnology
$17.03 +$0.00 (0.00%)
Market closed · Oct 8, 12:00 am ET
Open$0.00
Prev close$17.03
Day range$0.00 – $0.00
Volume0.00
Market cap$884.18M
P/E (TTM)16.4
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings16.4x
CheapRich

Near the top of its 5-year range · 86th percentile, 5-year average 2.0x

#1293 of 2973 stocks by PE (1 = cheapest)

Price / book3.1x
CheapRich

Near the top of its 5-year range · 83rd percentile, 5-year average 1.5x

#3696 of 5317 stocks by PB (1 = cheapest)

Price / sales8.5x
CheapRich

Below its usual level · 37th percentile, 5-year average 10.0x

#4321 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-25x6x37x68xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$16.49
Price vs. fair value+3.3%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.05 – 1.47 83% (pricier than usual) #3696 of 5317 (1 = cheapest)
PE 16.38 6.78 1.95 86% (pricier than usual) #1293 of 2973 (1 = cheapest)
PS 8.48 10.28 10.04 37% (cheaper than usual) #4321 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$16.49
Economic moatNarrow
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on TBPH.

Leave a comment

Scroll to Top